Disclaimer for Compounded GLP-1 Weight Loss Medications

Individual Results May Vary: The effectiveness of compounded GLP-1 medications, including semaglutide and tirzepatide, for medical weight loss varies from person to person. Results depend on various factors, including individual health conditions, adherence to prescribed treatment plans, lifestyle changes, and other variables.

Compounded Medications and FDA Status: The compounded semaglutide and tirzepatide medications prescribed by ZYP through Strive Pharmacy have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, efficacy, or quality. Unlike Wegovy® (semaglutide), which is FDA-approved specifically for weight loss, and Ozempic® (semaglutide), which is FDA-approved for type 2 diabetes treatment (but may be prescribed off-label for weight loss), the compounded versions of these medications do not carry FDA approval.

Medical Discretion and Compounding: At ZYP, a licensed healthcare provider may prescribe compounded medications like semaglutide and tirzepatide if it is determined that they are medically appropriate and necessary for your specific health needs. Compounded medications are custom-made by a licensed pharmacy based on a healthcare provider's prescription and may be used when an FDA-approved medication is not suitable for a particular patient.

Risks and Considerations: It is important to understand that while compounded medications are often prescribed to meet individual needs, they may carry risks, including variations in potency, purity, and safety. Patients should discuss potential risks, benefits, and alternatives with their healthcare provider before starting any compounded medication.

Patient Responsibility: By choosing to use compounded GLP-1 medications for weight loss, you acknowledge that you have been informed of the potential risks, benefits, and alternatives and have discussed these with your healthcare provider. You also agree to follow the treatment plan prescribed by your healthcare provider and to promptly report any side effects or concerns.

No Guarantee of Results: ZYP does not guarantee specific weight loss outcomes with the use of compounded GLP-1 medications. Weight loss results may vary widely among individuals based on a variety of factors.

Ongoing Monitoring: Regular follow-up appointments and monitoring are essential to ensure the safe and effective use of compounded GLP-1 medications. Your healthcare provider may adjust your treatment plan as needed based on your progress and any side effects experienced.

Legal and Regulatory Compliance: ZYP operates in compliance with all applicable state and federal regulations regarding the prescribing and dispensing of compounded medications. However, patients should be aware of the regulatory differences between compounded and FDA-approved medications.

Disclaimer for ZYP's GLP-1 Weight Loss Program

By participating in ZYP's GLP-1 weight loss program, which includes the use of compounded medications such as semaglutide and tirzepatide, you acknowledge and agree to the following:

  1. FDA Shortage Status: The medications used in this program are currently compounded by pharmacies under the FDA's Shortage List status. If semaglutide or tirzepatide are removed from this list by the FDA, compounding pharmacies may no longer be legally allowed to compound these medications. This status is subject to change, and ZYP does not control the regulatory decisions made by the FDA.

  2. Potential Disruption of Service: In the event that compounding of these medications becomes prohibited, ZYP will be unable to continue prescribing them. This could result in a disruption of your treatment, potentially leading to unsatisfactory weight loss outcomes or the regaining of any weight previously lost during the course of the program. ZYP is committed to assisting you in finding alternative treatment options, but we cannot guarantee that similar results will be achieved without the use of semaglutide or tirzepatide.

  3. Patient Responsibility: You understand that your continued progress in the weight loss journey may require adjustments to your treatment plan if these medications become unavailable. ZYP will work with you to explore alternative options, but it is important to note that achieving similar weight loss results may not be possible without semaglutide or tirzepatide. Your dedication to the program and adherence to any new treatment plan will be critical to your success.